The observed high incidence of smoking amongst depressed individuals has led to the hypothesis of 'self medication" with nicotine in some of these patients. The inbred Wistar-Kyoto (WKY) rats exhibit depressive-like characteristics as evidenced by exaggerated immobility in the forced swim test (FST). One aim of this study was to investigate whether nicotine may have an antidepressant-like effect in these animals. Moreover, because of human postmortem studies indicating a reduction of the hippocampus volume in depressed patients, it was of interest to determine whether such an anatomical anomaly may also be manifested in WKY rats and whether it would be affected by chronic nicotine treatment. Adult female WKY and their control Wistar rats were administered nicotine consecutively (0.2 mg/kg, i.p., once or twice daily for 14 days) and their activity in an open field, as well as their immobility in FST were assessed either 15 min or 18 h after the last injection. Another set of animals was treated twice daily with 0.2 mg/kg nicotine for 14 days and sacrificed on day 15 for stereological evaluation of the hippocampal volume. When tested 15 min after the last injection, once or twice daily nicotine exacerbated the immobility in the FST in WKY rats only. When tested 18 h after the last injection, only twice daily nicotine treatment resulted in less immobility in the FST in WKY rats. Open field locomotor activity was not affected by any nicotine regimen. WKY rats had significantly less hippocampal volume (approximately 20%) than Wistar rats which was not altered by nicotine. These findings further validate the use of WKY rats as an animal model of human depression and signify the importance of inherent genetic differences in final behavioral outcome of nicotine.
Introduction
It is well documented that the incidence of smoking is much higher in various neuropsychiatric disorders including depression compared to general population (see reviews: Glassman, 1993; Quattrocki et al., 2000) . Although common genetic risk factors may contribute to the co-morbid condition of nicotine dependence and depression (Kendler et al., 1993; Fu et al., 2007; Lyons et al., 2008) , a number of preclinical as well as controlled human studies have reported an antidepressantlike effect of nicotine (Semba et al., 1998 , Djuric et al., 1999 Tizabi et al., 1999 Tizabi et al., , 2000 Ferguson et al., 2000; McClernon et al., 2006) . Moreover, depressed patients are less likely to quit smoking compared to non-depressed individuals (Hughes, 2007; Leventhal et al., 2008; Thorndike et al., 2008) . Thus, it has been postulated that at least a subpopulation of depressed patients may be smoking to self medicate with tobacco's nicotine (Cook et al., 2007; Moreno-Coutiño et al., 2007; Spring et al., 2008) . Although it might be difficult to conceptualize a true animal model of human depression, various rat models with construct and predictive validity have been introduced. Previously, it was reported that Flinders Sensitive Line (FSL) rats exhibit depressive-like characteristics compared to their control the Flinders Resistant Line (FRL) rats. FSL rats are so designated because of their sensitivity to the toxic effects of the organophosphate cholinesterase inhibitors. However, it was later discovered that these inbred rats show remarkable immobility in the forced swim test (FST), reflective of their helplessness and hence depressive-like characteristic (see review: Overstreet et al., 2005) . Furthermore, injection or oral administration of nicotine resulted in an antidepressant-like effect in this model (Djuric et al., 1999; Tizabi et al., 1999 Tizabi et al., , 2000 .
Wistar Kyoto (WKY) rats represent another putative animal model of depression as these genetically inbred rats also exhibit exaggerated immobility in the FST and are prone to develop stress-induced ulcer or anxiety-like characteristics (Soderpalm, 1989; Paré and Redei, 1993; Getachew et al., 2008 
